Information  X 
Enter a valid email address

Alliance Pharma PLC (APH)

  Print      Mail a friend       Annual reports

Monday 12 November, 2018

Alliance Pharma PLC

Director Share Dealing

RNS Number : 1014H
Alliance Pharma PLC
12 November 2018
 

12 November 2018

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Director Share Dealing

Alliance Pharma plc (AIM: APH), the international specialty pharmaceutical group, announces that it was notified on 9 November 2018 that, on the same day, John Dawson, Non-Executive Director, sold 1,100,000 ordinary shares of 1 pence each in the Company at a price of 70.1 pence per share.

Following this transaction, Mr Dawson's total interest in the Company is 55,476,402 ordinary shares, representing approximately 10.71 per cent of the Company's current issued share capital (comprised of a total beneficial interest in 35,476,402 Ordinary Shares, representing 6.85 per cent of the issued share capital, and a total non-beneficial interest in 20,000,000 Ordinary Shares, representing 3.86 per cent of the issued share capital).

 

For further information:

 

Alliance Pharma plc

+ 44 (0)1249 466966

Peter Butterfield, Chief Executive Officer


Andrew Franklin, Chief Financial Officer


www.alliancepharma.co.uk


Buchanan

+ 44 (0)20 7466 5000

Mark Court / Sophie Wills / Gemma Mostyn-Owen




Numis Securities Limited

+ 44 (0)20 7260 1000

Nominated Adviser: Michael Meade / Freddie Barnfield


Corporate Broking: James Black


 

Investec Bank plc

+ 44 (0)  20 7597 5970

Corporate Finance: Daniel Adams / Ed Thomas


Corporate Broking: Patrick Robb / David Herring


 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by person discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr John Dawson

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Alliance Pharma plc

b)

Legal Entity Identifier

213800RYIWZA4Q5WPZ13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1.0 pence each

 

 

 

ISIN: GB0031030819

b)

Nature of the transaction

Sale of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price (p)

Volume(s)

70.1p

1,100,000

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

1,100,000 ordinary shares

70.1p

£770,720.01

f)

Date of the transaction

9 November 2018

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHFKBDQPBDDFDD

a d v e r t i s e m e n t